• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.一种用于复制缺陷型 E1 缺失型腺病毒增殖的新型互补细胞系。
Cytotechnology. 2006 Jul;51(3):133-40. doi: 10.1007/s10616-006-9023-6. Epub 2006 Nov 18.
2
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.新型辅助细胞和匹配的E1区缺失腺病毒载体可防止产生具有复制能力的腺病毒。
Hum Gene Ther. 1998 Sep 1;9(13):1909-17. doi: 10.1089/hum.1998.9.13-1909.
3
Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture.用于在无血清悬浮培养中生产E1缺失腺病毒载体的新型互补细胞的建立与验证
J Virol Methods. 2014 Nov;208:177-88. doi: 10.1016/j.jviromet.2014.08.013. Epub 2014 Aug 23.
4
Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses.建立一种新型细胞系,用于生产具有复制能力的无复制缺陷腺病毒。
BMC Biotechnol. 2024 Sep 27;24(1):67. doi: 10.1186/s12896-024-00894-x.
5
Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.源自人肺癌A549细胞的新型互补细胞系支持E1缺失腺病毒载体的生长。
Gene Ther. 1996 Jan;3(1):75-84.
6
A recombinant E1-deleted porcine adenovirus-3 as an expression vector.一种作为表达载体的重组E1缺失型猪3型腺病毒。
Virology. 2003 Sep 1;313(2):377-86. doi: 10.1016/s0042-6822(03)00286-1.
7
Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.将转化细胞的互补功能与选定病毒基因的稳定表达相匹配,以生产E1缺失的腺病毒载体。
Virology. 2006 Feb 5;345(1):220-30. doi: 10.1016/j.virol.2005.09.029. Epub 2005 Oct 24.
8
A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.一种用于腺病毒早期区域E1和E4完全功能互补的基因转移载体-细胞系系统。
J Virol. 1996 Sep;70(9):6497-501. doi: 10.1128/JVI.70.9.6497-6501.1996.
9
Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.能够互补E1、E4和IX蛋白缺陷型5型腺病毒突变体的细胞系的开发。
Hum Gene Ther. 1995 Dec;6(12):1575-86. doi: 10.1089/hum.1995.6.12-1575.
10
Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.利用病毒基因组的包装大小限制,开发一种无复制能力的重组腺病毒载体生产系统。
Virus Res. 2011 Jun;158(1-2):154-60. doi: 10.1016/j.virusres.2011.03.026. Epub 2011 Apr 4.

引用本文的文献

1
A Method to Generate and Rescue Recombinant Adenovirus Devoid of Replication-Competent Particles in Animal-Origin-Free Culture Medium.一种在无动物源培养基中生成和拯救不含复制能力颗粒的重组腺病毒的方法。
Viruses. 2023 Oct 25;15(11):2152. doi: 10.3390/v15112152.
2
Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety.临床应用的腺病毒基因治疗载体 - 以复制型腺病毒形成及其对临床安全性的影响为例的基本方面。
Int J Mol Sci. 2023 Nov 20;24(22):16519. doi: 10.3390/ijms242216519.
3
Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.一种表达土拉热弗朗西斯菌Tul4的腺病毒载体疫苗提供的针对兔热病的保护性免疫。
Clin Vaccine Immunol. 2012 Mar;19(3):359-64. doi: 10.1128/CVI.05384-11. Epub 2012 Jan 25.
4
Adenoviral producer cells.腺病毒生产细胞。
Viruses. 2010 Aug;2(8):1681-1703. doi: 10.3390/v2081681. Epub 2010 Aug 16.
5
An adenoviral vector-based mucosal vaccine is effective in protection against botulism.基于腺病毒载体的黏膜疫苗能有效预防肉毒中毒。
Gene Ther. 2009 Mar;16(3):367-75. doi: 10.1038/gt.2008.181. Epub 2009 Jan 8.
6
Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine.单剂量腺病毒载体疫苗接种提供的针对肉毒中毒的保护性免疫。
Vaccine. 2007 Oct 23;25(43):7540-8. doi: 10.1016/j.vaccine.2007.08.035. Epub 2007 Sep 5.

本文引用的文献

1
N-fragment of edema factor as a candidate antigen for immunization against anthrax.水肿因子的N片段作为抗炭疽免疫的候选抗原
Vaccine. 2006 Jan 30;24(5):662-70. doi: 10.1016/j.vaccine.2005.08.056. Epub 2005 Aug 26.
2
Adenovirus-based genetic vaccines for biodefense.用于生物防御的腺病毒基因疫苗。
Hum Gene Ther. 2005 Feb;16(2):157-68. doi: 10.1089/hum.2005.16.157.
3
Biology of adenovirus and its use as a vector for gene therapy.腺病毒生物学及其作为基因治疗载体的应用。
Hum Gene Ther. 2004 Nov;15(11):1022-33. doi: 10.1089/hum.2004.15.1022.
4
Plaque assay for avian metapneumovirus using a Japanese quail fibrosarcoma cell line (QT-35).使用日本鹌鹑纤维肉瘤细胞系(QT-35)进行禽偏肺病毒的蚀斑测定。
J Virol Methods. 2003 Jan;107(1):9-14. doi: 10.1016/s0166-0934(02)00207-0.
5
Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines.通过无针接种腺病毒载体鼻用和皮上疫苗预防破伤风。
J Virol. 2001 Dec;75(23):11474-82. doi: 10.1128/JVI.75.23.11474-11482.2001.
6
Development of a packaging cell line for propagation of replication-deficient adenovirus vector.
Exp Mol Med. 2001 Sep 30;33(3):145-9. doi: 10.1038/emm.2001.25.
7
AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination.
Biotechniques. 2001 Aug;31(2):260-2. doi: 10.2144/01312bm04.
8
Characterization and quality control of recombinant adenovirus vectors for gene therapy.
J Chromatogr B Biomed Sci Appl. 2001 Mar 10;752(2):263-80. doi: 10.1016/s0378-4347(00)00557-0.
9
Guidance for human somatic cell therapy and gene therapy.人类体细胞治疗和基因治疗指南。
Hum Gene Ther. 2001 Feb 10;12(3):303-14. doi: 10.1089/10430340150218431.
10
Production of first generation adenovirus vectors: a review.第一代腺病毒载体的生产:综述
Gene Ther. 2000 Oct;7(20):1707-14. doi: 10.1038/sj.gt.3301301.

一种用于复制缺陷型 E1 缺失型腺病毒增殖的新型互补细胞系。

A new complementing cell line for replication-incompetent E1-deleted adenovirus propagation.

机构信息

Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 672, Rochester, NY, 14642, USA.

出版信息

Cytotechnology. 2006 Jul;51(3):133-40. doi: 10.1007/s10616-006-9023-6. Epub 2006 Nov 18.

DOI:10.1007/s10616-006-9023-6
PMID:19002883
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3449810/
Abstract

Recombinant adenoviruses (Ad) are being explored as promising delivery systems for gene therapy and vaccination. However, there is a concern about the possibility of generating replication-competent adenoviruses (RCA) using the human embryonic kidney 293 cell line. We have constructed a new cell line named the UR cell line which can be used to produce Ad vectors free of RCA. This cell line is based on the human embryonic lung HEL 299 cell. We first constructed a shuttle plasmid which encodes the E1A/E1B sequence that is necessary for adenovirus replication. The shuttle plasmid was then transfected into HEL 299 cells. The presence of the E1A/E1B sequence and protein expression in the stably transformed UR cells was confirmed. Viruses produced in UR cells were still RCA-free after ten test passages, while adenovirus produced in 293 cells had generated RCA during the fourth passage. We conclude that the UR cell line is sufficiently stable, can effectively produce a virus yield comparable with 293 cells, and does not generate RCA formation during Ad propagation.

摘要

重组腺病毒(Ad)被探索作为基因治疗和疫苗接种的有前途的传递系统。然而,人们担心使用人胚肾 293 细胞系可能会产生复制能力的腺病毒(RCA)。我们构建了一种新的细胞系,命名为 UR 细胞系,可用于生产无 RCA 的 Ad 载体。该细胞系基于人胚肺 HEL 299 细胞。我们首先构建了一个穿梭质粒,其编码腺病毒复制所必需的 E1A/E1B 序列。然后将穿梭质粒转染到 HEL 299 细胞中。在稳定转化的 UR 细胞中证实了 E1A/E1B 序列的存在和蛋白表达。在 UR 细胞中产生的病毒在经过十次测试传代后仍然没有 RCA,而在 293 细胞中产生的腺病毒在第四代时已经产生了 RCA。我们得出结论,UR 细胞系足够稳定,能够有效地产生与 293 细胞相当的病毒产量,并且在 Ad 繁殖过程中不会产生 RCA 形成。